These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Mutational spectrum of tobacco associated oral squamous carcinoma and its therapeutic significance. Batta N; Pandey M World J Surg Oncol; 2019 Nov; 17(1):198. PubMed ID: 31775759 [TBL] [Abstract][Full Text] [Related]
4. Somatic copy number alterations detected by ultra-deep targeted sequencing predict prognosis in oral cavity squamous cell carcinoma. Peng CH; Liao CT; Ng KP; Tai AS; Peng SC; Yeh JP; Chen SJ; Tsao KC; Yen TC; Hsieh WP Oncotarget; 2015 Aug; 6(23):19891-906. PubMed ID: 26087196 [TBL] [Abstract][Full Text] [Related]
5. Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer. van Ginkel JH; de Leng WW; de Bree R; van Es RJ; Willems SM Oncotarget; 2016 Sep; 7(38):61575-61586. PubMed ID: 27528217 [TBL] [Abstract][Full Text] [Related]
6. Clues toward precision medicine in oral squamous cell carcinoma: utility of next-generation sequencing for the prognostic stratification of high-risk patients harboring neck lymph node extracapsular extension. Wang HM; Liao CT; Yen TC; Chen SJ; Lee LY; Hsieh CH; Lin CY; Ng SH Oncotarget; 2016 Sep; 7(39):63082-63092. PubMed ID: 27590518 [TBL] [Abstract][Full Text] [Related]
7. Receptor tyrosine kinase amplification is predictive of distant metastasis in patients with oral squamous cell carcinoma. Oikawa Y; Morita KI; Kayamori K; Tanimoto K; Sakamoto K; Katoh H; Ishikawa S; Inazawa J; Harada H Cancer Sci; 2017 Feb; 108(2):256-266. PubMed ID: 27889930 [TBL] [Abstract][Full Text] [Related]
8. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications. Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047 [TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of oral squamous cell carcinoma using targeted next-generation sequencing. Er TK; Wang YY; Chen CC; Herreros-Villanueva M; Liu TC; Yuan SS Oral Dis; 2015 Oct; 21(7):872-8. PubMed ID: 26173098 [TBL] [Abstract][Full Text] [Related]
10. Mutant GDF15 presents a poor prognostic outcome for patients with oral squamous cell carcinoma. Ma J; Tang X; Sun WW; Liu Y; Tan YR; Ma HL; Zhu DW; Wang M; Wang LZ; Li J; Tu YY; Zhang CP; Zhang ZY; Zhong LP Oncotarget; 2016 Jan; 7(2):2113-22. PubMed ID: 26544895 [TBL] [Abstract][Full Text] [Related]
11. Genomic characterization of esophageal squamous cell carcinoma: Insights from next-generation sequencing. Sasaki Y; Tamura M; Koyama R; Nakagaki T; Adachi Y; Tokino T World J Gastroenterol; 2016 Feb; 22(7):2284-93. PubMed ID: 26900290 [TBL] [Abstract][Full Text] [Related]
12. Mutation allele frequency threshold does not affect prognostic analysis using next-generation sequencing in oral squamous cell carcinoma. Ma J; Fu Y; Tu YY; Liu Y; Tan YR; Ju WT; Pickering CR; Myers JN; Zhang ZY; Zhong LP BMC Cancer; 2018 Jul; 18(1):758. PubMed ID: 30041611 [TBL] [Abstract][Full Text] [Related]
13. Profiling cancer-related gene mutations in oral squamous cell carcinoma from Japanese patients by targeted amplicon sequencing. Nakagaki T; Tamura M; Kobashi K; Koyama R; Fukushima H; Ohashi T; Idogawa M; Ogi K; Hiratsuka H; Tokino T; Sasaki Y Oncotarget; 2017 Aug; 8(35):59113-59122. PubMed ID: 28938622 [TBL] [Abstract][Full Text] [Related]
14. Somatic mutations in plasma cell-free DNA are diagnostic markers for esophageal squamous cell carcinoma recurrence. Ueda M; Iguchi T; Masuda T; Nakahara Y; Hirata H; Uchi R; Niida A; Momose K; Sakimura S; Chiba K; Eguchi H; Ito S; Sugimachi K; Yamasaki M; Suzuki Y; Miyano S; Doki Y; Mori M; Mimori K Oncotarget; 2016 Sep; 7(38):62280-62291. PubMed ID: 27556701 [TBL] [Abstract][Full Text] [Related]
15. Exome sequencing of oral squamous cell carcinoma in users of Arabian snuff reveals novel candidates for driver genes. Al-Hebshi NN; Li S; Nasher AT; El-Setouhy M; Alsanosi R; Blancato J; Loffredo C Int J Cancer; 2016 Jul; 139(2):363-72. PubMed ID: 26934577 [TBL] [Abstract][Full Text] [Related]
16. Hot spot mutations in Finnish non-small cell lung cancers. Mäki-Nevala S; Sarhadi VK; Rönty M; Kettunen E; Husgafvel-Pursiainen K; Wolff H; Knuuttila A; Knuutila S Lung Cancer; 2016 Sep; 99():102-10. PubMed ID: 27565922 [TBL] [Abstract][Full Text] [Related]
17. Somatic mutations in oral squamous cell carcinomas in 98 Japanese patients and their clinical implications. Osawa Y; Aoyama KI; Hosomichi K; Uchibori M; Tajima A; Kimura M; Ota Y Cancer Treat Res Commun; 2021; 29():100456. PubMed ID: 34563788 [TBL] [Abstract][Full Text] [Related]
18. Relevance and actionable mutational spectrum in oral squamous cell carcinoma. Jayaprakash C; Varghese VK; Jayaram P; Chakrabarty S; Kudva A; Ray S; Satyamoorthy K J Oral Pathol Med; 2020 May; 49(5):427-434. PubMed ID: 31845386 [TBL] [Abstract][Full Text] [Related]
19. Genomic profiling of esophageal squamous cell carcinoma (ESCC)-Basis for precision medicine. Yang JW; Choi YL Pathol Res Pract; 2017 Jul; 213(7):836-841. PubMed ID: 28554745 [TBL] [Abstract][Full Text] [Related]
20. Genetic alteration profiling of patients with resected squamous cell lung carcinomas. Tao D; Han X; Zhang N; Lin D; Wu D; Zhu X; Song W; Shi Y Oncotarget; 2016 Jun; 7(24):36590-36601. PubMed ID: 27145277 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]